Back
Nippon Telegraph & Telephone Vs. Spyre Therapeutics Industry Stock Comparison
Sell
38
NTTYY
Nippon Telegraph & Telephone
Last Price:
24.01
Seasonality Move:
-0.26%
Buy
76
SYRE
Spyre Therapeutics
Last Price:
34.38
Seasonality Move:
10.02%
Sell
38
Nippon Telegraph & Telephone (NTTYY)
is a Sell
Is Nippon Telegraph & Telephone a Buy, Sell or Hold?
- The current Nippon Telegraph & Telephone [NTTYY] share price is $24.02. The Score for NTTYY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- NTTYY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
76
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $33.80. The Score for SYRE is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTTYY Stock Price Chart
What is Nippon Telegraph & Telephone's stock price today?
-
The Nippon Telegraph & Telephone share price today is $24.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTTYY is experiencing slight buying pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $33.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing slight selling pressure.
NTTYY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 32.68 | Sell |
| Chaikin Money Flow: | 27588 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.16 - 25.54) | Sell |
| Bollinger Bands (100): | (24.05 - 26.27) | Sell |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.58 | Buy |
| Relative Strength Index (14 RSI): | 63.15 | Buy |
| Chaikin Money Flow: | -1743 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.69 - 32.97) | Buy |
| Bollinger Bands (100): | (25.39 - 31.79) | Buy |
NTTYY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.04 | Sell |
| 20-day SMA: | 24.61 | Sell |
| 50-day SMA: | 25.67 | Sell |
| 200-day SMA: | 27 | Sell |
| 8-day EMA: | 24.09 | Sell |
| 20-day EMA: | 24.57 | Sell |
| 50-day EMA: | 25.16 | Sell |
| 200-day EMA: | 26.47 | Sell |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.71 | Buy |
| 20-day SMA: | 30.78 | Buy |
| 50-day SMA: | 29.22 | Buy |
| 200-day SMA: | 30.56 | Buy |
| 8-day EMA: | 33.41 | Buy |
| 20-day EMA: | 31.69 | Buy |
| 50-day EMA: | 30.04 | Buy |
| 200-day EMA: | 28.04 | Buy |
Nippon Telegraph & Telephone Earnings Growth & NTTYY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.01 per share, and a decrease next year of $0.09 per share.
Nippon Telegraph & Telephone Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||